Medprin Regenerative Medical Technologies Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Medprin Regenerative Medical Technologies Co., Ltd.

Why is Medprin Regenerative Medical Technologies Co., Ltd. ?

With a growth in Net Profit of 39.89%, the company declared Outstanding results in Sep 25

The company has declared positive results for the last 6 consecutive quarters
OPERATING CASH FLOW(Y) Highest at CNY 136.76 MM
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
ROCE(HY) Highest at 14.41%

Market Beating Performance

The stock has generated a return of 31.09% in the last 1 year, much higher than market (China Shanghai Composite) returns of 16.01%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Medprin Regenerative Medical Technologies Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medprin Regenerative Medical Technologies Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Medprin Regenerative Medical Technologies Co., Ltd.

31.09%

1.10

56.68%

China Shanghai Composite

16.01%

1.07

14.97%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.91%

EBIT Growth (5y)

59.77%

EBIT to Interest (avg)

35.56

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

0.38

Tax Ratio

14.29%

Dividend Payout Ratio

50.34%

Pledged Shares

Institutional Holding

ROCE (avg)

9.56%

ROE (avg)

8.17%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.85

EV to EBIT

50.64

EV to EBITDA

38.71

EV to Capital Employed

9.60

EV to Sales

15.19

PEG Ratio

1.00

Dividend Yield

0.18%

ROCE (Latest)

18.96%

ROE (Latest)

13.12%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 136.76 MM

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

ROCE(HY)

Highest at 14.41%

RAW MATERIAL COST(Y)

Fallen by -16.86% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -33.96 %

NET SALES(Q)

Highest at CNY 91.45 MM

PRE-TAX PROFIT(Q)

Highest at CNY 32.64 MM

NET PROFIT(Q)

Highest at CNY 28.27 MM

EPS(Q)

Highest at CNY 0.43

-2What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.06 times

OPERATING PROFIT MARGIN(Q)

Lowest at 32.11 %

Here's what is working for Medprin Regenerative Medical Technologies Co., Ltd.

Operating Cash Flow

Highest at CNY 136.76 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 91.45 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 91.45 MM has Grown at 32.74%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 32.64 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 28.27 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.43

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Lowest at -33.96 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -16.86% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medprin Regenerative Medical Technologies Co., Ltd.

Operating Profit Margin

Lowest at 32.11 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 2.06 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio